Surgery Websites
Hepatobiliary & Pancreatic Surgery »  Meet the Team »  Hepatology »  Bilal Hameed, M.D.

Bilal Hameed, M.D.

Assistant Professor of Medicine
Hepatology and Liver Transplantation
Department of Medicine

Contact Information

Academic Office
Division of Gastroenterology
513 Parnassus Avenue, Room S-357
San Francisco, CA 94143-0358
Phone: (415) 514-2860
415-476-0659
Bilal.Hameed@ucsf.edu
Open Popup

1995-2000 Dow Medical College, M.B.B.S.

 

  • 2003-2006 University of Minnesota, Minneapolis, Internal Medicine Residency
  • 2006-2009 University of Minnesota, Minneapolis, Gastroenterology Fellowship

  • 2009-2010 University of California, San Francisco, Transplant Hepatology Fellowship
  • American Board of Internal Medicine
  • American Board of Internal Medicine - Gastroenterology
  • UCSF Liver Transplantation Program
  • Epidemiology and management of NAFLD
  • Modeling outcomes in advanced liver disease and liver transplantation.
  • Sleep apnea in NAFLD

Bilal Hameed, M.D. is an Assistant Professor of Medicine and hepatologist at UCSF who treats patients with liver disease and plays an integral role in the multidisciplinary Liver Transplantation Program.

Dr. Hameed received his medical degree from Dow Medical College, completed an internal medicine residency at the University of Minnesota, and consecutive fellowships at the University of Minnesota and UCSF, in the areas of gastroenterology and transplant hepatology respectively. Dr. Hameed is board certified by the American Board of Internal Medicine with a general certificate in internal medicine and a subspeciality in gastroenterology.

Dr. Hameed is a member of American Association for the Study of Liver Diseases, American Gastroenterological Association. and American Society of Transplantation. He is author of numerous peer-reviewed articles and the recipient of many awards and honors in his field. He is also fluent languages of  Punjabi and Urdu.

Data provided by UCSF Profiles, powered by CTSI
MOST RECENT PUBLICATIONS FROM A TOTAL OF 45
Data provided by UCSF Profiles, powered by CTSI
  1. Fontana RJ, Stravitz RT, Durkalski V, Hanje J, Hameed B, Koch D, Ganger D, Olson J, Liou I, McGuire BM, Clasen K, Lee WM. Prognostic Value of the 13 C-Methacetin Breath Test in Adults with Acute Liver Failure and Non-acetaminophen Acute Liver Injury. Hepatology. 2021 Aug; 74(2):961-972. View in PubMed
  2. Fix OK, Blumberg EA, Chang KM, Chu J, Chung RT, Goacher EK, Hameed B, Kaul DR, Kulik LM, Kwok RM, McGuire BM, Mulligan DC, Price JC, Reau NS, Reddy KR, Reynolds A, Rosen HR, Russo MW, Schilsky ML, Verna EC, Ward JW, Fontana RJ, AASLD COVID-19 Vaccine Working Group . American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease. Hepatology. 2021 08; 74(2):1049-1064. View in PubMed
  3. Mehta N, Parikh ND, Kelley RK, Hameed B, Singal AG. Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic. Clin Gastroenterol Hepatol. 2021 08; 19(8):1520-1530. View in PubMed
  4. Veracruz N, Hameed B, Saab S, Wong RJ. The Association Between Nonalcoholic Fatty Liver Disease and Risk of Cardiovascular Disease, Stroke, and Extrahepatic Cancers. J Clin Exp Hepatol. 2021 Jan-Feb; 11(1):45-81. View in PubMed
  5. Fix OK, Hameed B, Fontana RJ, Kwok RM, McGuire BM, Mulligan DC, Pratt DS, Russo MW, Schilsky ML, Verna EC, Loomba R, Cohen DE, Bezerra JA, Reddy KR, Chung RT. Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement. Hepatology. 2020 07; 72(1):287-304. View in PubMed
  6. View All Publications

 

Site Directory
    X